Why Moderna Stock Just Crashed 21%
's (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot.
The coronavirus vaccine maker's shares plunged 21.2% through 10:20 a.m. ET Monday after it updated investors on its 2024 performance and released new guidance for 2025.
Moderna estimates it ended 2024 with somewhere between $3 billion and $3.1 billion in product sales as it shifted its business toward treating COVID-19 as an "endemic" illness rather than a novel and spreading pandemic. CEO Stéphane Bancel said Moderna has cut its "cash operating cost by over 25 percent compared to 2023" and plans to make further cost cuts of $1 billion in 2025 and $500 million more in 2026, which should boost profits.
Source Fool.com
Moderna Inc. Stock
€51.17
9.870%
Currently there is a rather positive sentiment for Moderna Inc. with 11 Buy predictions and 8 Sell predictions.
However, we have a potential of -58.96% for Moderna Inc. as the target price of 21 € is below the current price of 51.17 €.
